Home blood pressure monitoring in France: Device possession rate and associated determinants, the Esteban study.
drug treatment
healthcare
home blood pressure monitoring
hypertension
socioeconomic status
Journal
Journal of clinical hypertension (Greenwich, Conn.)
ISSN: 1751-7176
Titre abrégé: J Clin Hypertens (Greenwich)
Pays: United States
ID NLM: 100888554
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
30
07
2020
revised:
24
08
2020
accepted:
04
09
2020
pubmed:
24
9
2020
medline:
29
5
2021
entrez:
23
9
2020
Statut:
ppublish
Résumé
Home blood pressure monitoring (HBPM) is increasingly being promoted in hypertension guidelines to improve hypertension management. Possessing a HBPM device could improve blood pressure (BP) control and prognostic impact. The aims of this study were to estimate the possession rate of HBPM devices in the French population and in hypertensive adults, and to investigate the determinants of possessing such devices at home. Cross-sectional analyses were performed using data from the Esteban survey, which comprised a representative sample of the French population. Among the 2,054 study participants, 673 had hypertension. Of these, 385 were aware they had it. Weighted logistic regressions were performed to investigate the factors (socioeconomic, clinical, drug treatment, and healthcare visits) associated with possessing a HBPM device. 20.9% of the study sample, 42.1% of those with hypertension, and 54% of those aware of their hypertension, possessed a HBPM device. Female gender (OR = 2.03, 95%CI [1.46; 2.60]), smoking (OR = 2.33, 95%CI [1.51; 3.15]), antihypertensive drugs (OR = 1.75, 95%CI [1.06; 2.44]), general practitioner (GP) visits (OR = 3.28, 95%CI [1.84; 4.68]), and diabetes (OR = 0.41 95% CI [0.14; 0.68]) were associated with possessing a HBPM device among those aware of their hypertension. Over 20% of the study population possessed a HBPM device at home. This proportion rose to one in two in those aware or their hypertension. Among the latter, possessing a device was positively associated with female gender, GP visits, and antihypertensive drug use. Increasing possession of HBPM devices in the hypertensive population could foster better management of the condition.
Identifiants
pubmed: 32966691
doi: 10.1111/jch.14055
pmc: PMC8030053
doi:
Substances chimiques
Antihypertensive Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2204-2213Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Am J Hypertens. 2017 Nov 1;30(11):1126-1132
pubmed: 28633432
Hypertension. 2019 Jul 1;:HYPERTENSIONAHA11912630
pubmed: 31256719
Int J Hypertens. 2012;2012:582068
pubmed: 22013510
Lancet. 2012 Dec 15;380(9859):2224-60
pubmed: 23245609
J Hypertens. 1998 Jul;16(7):971-5
pubmed: 9794737
J Clin Hypertens (Greenwich). 2008 Sep;10(9):692-9
pubmed: 18844764
Lancet. 2014 Aug 16;384(9943):591-598
pubmed: 25131978
Am J Manag Care. 2009 Jul;15(7):457-64
pubmed: 19589013
Can J Cardiol. 2010 May;26(5):e152-7
pubmed: 20485694
Br J Gen Pract. 2012 Feb;62(595):e135-42
pubmed: 22520791
Ann Med. 2010 Jul;42(5):371-86
pubmed: 20504241
J Clin Hypertens (Greenwich). 2020 Apr;22(4):663-672
pubmed: 32092238
Curr Hypertens Rep. 2015 Dec;17(12):94
pubmed: 26560139
BMJ. 2004 Jul 17;329(7458):145
pubmed: 15194600
Rev Epidemiol Sante Publique. 2017 Oct;65 Suppl 4:S149-S167
pubmed: 28756037
Hypertension. 2010 Jun;55(6):1346-51
pubmed: 20385970
BMJ. 2005 Sep 3;331(7515):493
pubmed: 16115830
Medicine (Baltimore). 2017 Oct;96(43):e8363
pubmed: 29069022
J Clin Hypertens (Greenwich). 2006 Mar;8(3):174-80
pubmed: 16522994
J Clin Hypertens (Greenwich). 2008 Apr;10(4):280-6
pubmed: 18401225
J Clin Hypertens (Greenwich). 2017 Jun;19(6):584-591
pubmed: 28371252
Br J Gen Pract. 2016 Nov;66(652):e831-e837
pubmed: 27578811
Arch Intern Med. 2008 Apr 14;168(7):713-20
pubmed: 18413553
Am J Hypertens. 2020 Mar 13;33(3):243-251
pubmed: 31730171
J Clin Hypertens (Greenwich). 2020 Dec;22(12):2204-2213
pubmed: 32966691
J Hum Hypertens. 2004 Oct;18(10):725-31
pubmed: 15103315
J Clin Hypertens (Greenwich). 2018 Jul;20(7):1116-1121
pubmed: 30003694
Ann Intern Med. 2015 Nov 3;163(9):691-700
pubmed: 26457954
Am J Hypertens. 2019 Sep 24;32(10):1003-1012
pubmed: 31219160
Am J Hypertens. 2020 Sep 10;33(9):852-859
pubmed: 32542320
Am J Clin Nutr. 2010 Jan;91(1):106-14
pubmed: 19889820
Ann Intern Med. 2018 Mar 20;168(6):422-430
pubmed: 29459980
Hypertension. 2013 May;61(5):964-71
pubmed: 23478096
Ann Intern Med. 2013 Aug 6;159(3):185-94
pubmed: 23922064
J Hum Hypertens. 2005 Jul;19(7):559-64
pubmed: 15944723
Am J Hypertens. 2014 Nov;27(11):1339-45
pubmed: 24771706
PLoS One. 2019 Sep 11;14(9):e0220460
pubmed: 31509852
J Hypertens. 2008 Mar;26(3):446-52
pubmed: 18300854
Am J Hypertens. 2015 Oct;28(10):1209-21
pubmed: 25725092
J Hypertens. 2018 Dec;36(12):2284-2309
pubmed: 30379783
JAMA. 2013 Sep 4;310(9):959-68
pubmed: 24002282
Fundam Clin Pharmacol. 2014 Feb;28(1):1-9
pubmed: 23952903
J Hum Hypertens. 2014 Apr;28(4):224-9
pubmed: 24152822
PLoS Med. 2017 Sep 19;14(9):e1002389
pubmed: 28926573
J Hypertens. 2011 Nov;29(11):2105-15
pubmed: 21946694
Cureus. 2017 Apr 11;9(4):e1155
pubmed: 28503391
Lancet. 2018 Mar 10;391(10124):949-959
pubmed: 29499873
Nutrients. 2019 Jun 25;11(6):
pubmed: 31242675
Ann Cardiol Angeiol (Paris). 2013 Jun;62(3):200-3
pubmed: 23752137